| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |